Company Overview

Update
Founded:
2001
Founders:
Michael Carroll
Headquarters:
Boston, MA
Funding:
$5.50M
Categories:
Biotechnology

DecImmune Therapeutics is a Boston-based biotech company developing drugs for inflammation and autoimmunity.

Description

Update

DecImmune Therapeutics, Inc., a biotechnology company, manufactures drugs for inflammation and autoimmunity. The company was incorporated in 2001 and is based in Boston, Massachusetts.

Board Members and Advisors (1)

Update

Funding Rounds (2) - $5.50M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    800 Huntington Avenue

    Boston, MA 02115

    USA